Accendra Health Inc (ACH): PARADIGM CAPITAL MANAGEMENT INC/NY now owns 5.1% of ACH as a passive investor 5.1%
PARADIGM CAPITAL MANAGEMENT INC/NY now owns 5.1% of ACH as a passive investor.
- 5.1%
- Stake · was 5.1%
- 3.95M
- Shares owned
- Stake as of
- Sep 30, 2026
- Filed
- Nov 12, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 9, 2026Company filing · Form 8-K · Material agreement, Shareholder rightsSigned an important agreement, and changed the rights of its shareholders (and 2 more items)
- Aug 10, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Aug 10, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On August 10, 2026, Accendra Health, Inc. (the “Company”) announced that Edward A. Pesicka, President, Chief Executive Officer & Director of the Company, notified the board of directors (the “Board”) of the Company of his intention to retire and step down from the Board by the end of 2026, or such earlier time as a successor is appointed.”
- Sep 16, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors (and 1 more item)“On September 17, 2026, Accendra Health, Inc. (the “Company” or “Accendra Health”) announced that it named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer.”
- Sep 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 22, 2026, Accendra Health and Mr. Gardner-Smith, the Company’s next President and Chief Executive Officer, mutually agreed to an effective start date of October 5, 2026.”
What came next
- Oct 6, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On October 6, 2026 Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive…”
- Oct 7, 20265% stakeBANK OF AMERICA CORP /DE/ reported a passive stake (13G) of 10.8%
- Oct 27, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On October 27, 2026, Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE’s Listed Company Manual (“Section 802.01B”) that the Company have an average market capitalization of not less than $50.0 million over a consecutive 30 trading-day period and…”
- Oct 29, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
- Oct 29, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 29, 2026, Perry A. Bernocchi, the Company’s Executive Vice President, Chief Operating Officer, entered into a transition agreement with the Company under which Mr. Bernocchi will cease to be an executive officer and will serve as Strategic Advisor to the Chief Executive Officer until December 31, 2026, unless his employment ends earlier.”
- Nov 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Nov 12, 20265% stakePARADIGM CAPITAL MANAGEMENT INC/NY reported a passive stake (13G) of 5.1%
- Nov 16, 2026InsiderInsider sold ~$4K of ACH shares in the open market
- Nov 18, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On November 16, 2026, Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (“NYSE”) Regulation that it has suspended trading of the Company’s common stock and determined to commence proceedings to delist the Company’s common stock from the NYSE.”
How to read SEC Schedule 13G
A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.
Full guide: Schedule 13D vs Schedule 13G: what is the difference?
What else is on file for Accendra Health Inc
For Accendra Health Inc, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ACH page.
How this filing works
Explore the data
Common questions
What does this filing report about Accendra Health Inc (ACH) stock?
PARADIGM CAPITAL MANAGEMENT INC/NY now owns 5.1% of ACH as a passive investor. Of the company, Schedule 13G (passive).
When did it happen, and when was it made public?
Stake as of: Sep 30, 2026. Filed: Nov 12, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Schedule 13G, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Accendra Health Inc recently?
For Accendra Health Inc, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the ACH page.
Does this mean ACH stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Accendra Health Inc
- SEC Form 4Nov 17, 2026
- SEC Form 144Nov 16, 2026
- SEC Schedule 13GOct 7, 2026
- SEC Form 4Aug 15, 2025
- SEC Form 4Aug 15, 2025
- SEC Form 4Aug 15, 2025
Everything OQRO holds on this company is on its ACH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data